ClinicalTrials.Veeva

Menu

Bone Mass and Strength After Kidney Transplantation

Columbia University logo

Columbia University

Status and phase

Completed
Phase 2

Conditions

Vascular Calcifications
Kidney Transplantation
Fractures
End Stage Renal Disease
Bone Loss

Treatments

Drug: Placebo
Drug: Calcitriol
Drug: Vitamin D3

Study type

Interventional

Funder types

Other

Identifiers

NCT02224144
AAAM7850

Details and patient eligibility

About

The purpose of this study is to test whether active vitamin D (calcitriol) protects bones from weakening and protects blood vessels from calcium deposits over the first year of kidney transplantation.

Full description

Kidney transplant recipients at highest fracture risk, as determined by epidemiologic studies (Caucasians and older recipients). Rocaltrol (calcitriol) is a synthetic vitamin D analog which is active in the regulation of the absorption of calcium from the gastrointestinal tract and its utilization in the body.

Enrollment

61 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age older than 18
  • Self-describes as White race

Exclusion criteria

  • Lower extremity amputations
  • Non-ambulatory
  • Paget´s disease of bone
  • Current hyperthyroidism, untreated hypothyroidism
  • Medical diseases (end stage liver, intestinal malabsorption)
  • Use within the prior year pod anti-seizure medications that induce the cytochrome P450 system, testosterone, estrogen, selective estrogen receptor modulators
  • Weight >300 pounds
  • Dual organ transplant
  • Myocardial infarction or stroke
  • Tobacco use within the past year

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

61 participants in 2 patient groups, including a placebo group

Vitamin D3 plus Calcitriol
Experimental group
Description:
1 pill of Vitamin D3 (cholecalciferol) 1000 IU daily for 12 months 1 pill of Rocaltrol (calcitriol) 0.5 mcg daily for 12 months
Treatment:
Drug: Vitamin D3
Drug: Calcitriol
Vitamin D3 plus Placebo
Placebo Comparator group
Description:
1 pill of Vitamin D3 (cholecalciferol) 1000 IU per day for 12 months 1 pill of placebo (sugar pill) per day for 12 months
Treatment:
Drug: Vitamin D3
Drug: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems